CN104436112A

CN104436112A - Medicine for treating raynaud disease

Info

Publication number: CN104436112A
Application number: CN201410639531.5A
Authority: CN
Inventors: 李�杰; 吴润秀; 张爱萍; 黄结云; 黄志超; 曾令城
Original assignee: Individual
Current assignee: Individual
Priority date: 2014-11-13
Filing date: 2014-11-13
Publication date: 2015-03-25

Abstract

The invention provides a medicine for treating raynaud disease. The medicine is characterized by being prepared from the following components in parts by weight: 10 to 12 parts of astragalus membranaceus, 10 to 12 parts of as arum, 10 to 12 parts of rhizoma sparganii, 10 to 12 parts of radix pseudostellariae, 10 to 12 parts of caulis spatholobi, 10 to 12 parts of salvia miltiorrhiza, 10 to 12 parts of rhizoma curculiginis, 10 to 12 parts of herba epimedii, 10 to 12 parts of angelica sinensis, 10 to 12 parts of barbary wolfberry fruit, 10 to 12 parts of fructus liquidambaris, 10 to 12 parts of pangolin, 10 to 12 parts of radix clematidis, 10 to 12 parts of radix saposhnikoviae, 10 to 12 parts of rehmannia glutinosa, 10 to 12 parts of ligusticum wallichii, 10 to 12 parts of radix aucklandiae, 10 to 12 parts of fructus aurantii, 10 to 12 parts of cassia twig, 10 to 12 parts of honey-fried ephedra, 10 to 12 parts of rhizoma zingiberis, and 10 to 12 parts of liquorice. The medicine has the advantages that the raw materials are easily obtained, the cost is low, and the treatment effect is obvious.

Description

One treats raynaud disease medicine

Technical field

The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal formulae.

Background technology

Chinese medicine (Chinese herbology, Traditional Materia Medica), refers to the medicine of application under Han nationality's folk medicine instructs.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.Minority Chinese medicine comes from foreign country, as Radix Panacis Quinquefolii.China working people, for thousands of years in the process combated the disease, by practice, is constantly familiar with, have accumulated abundant medicinal knowledge gradually.Because word in period in romote antiquity is not emerging, these knowledge can only rely on transmission from master to disciple oral instruction, have had word afterwards, and have just recorded gradually, and occurred medical book.These books serve sums up forefathers' experience and is convenient to the effect spreading and promote.Chinese medicine has the history of thousands of years, and be that the very rich experience that Chinese people struggle with disease is for a long time summed up, the prosperity for the Chinese nation has huge contribution.Because medicine medium-height grass class is in the great majority, so the books recording medicine are just called " book on Chinese herbal medicine ".According to textual criticism, when Qin Han, book on Chinese herbal medicine is popular more, but these books on Chinese herbal medicine are lost all unfortunately, can not investigate.The herbal the earliest works now known is called Shennong's Herbal, pandect is totally three volumes, record medicine comprise dynamic, plant, ore deposit three class, totally 365 kinds, every medicine item is downloaded to be had nature and flavor, function and cures mainly, and another example in order describes the basic theories of medication briefly, as toxicity or no toxicity, four natures and five flavors of drug, compatibility law, method of administration and ball, fall apart, the dosage form such as cream, wine, can say it is the summary of China's knowledge of medication before the Chinese, and lay a good foundation for later pharmaceutical development.Greatest works in China's book on Chinese herbal medicine history, achievement extremely brilliant in the history of science of Ye Shi China.Now affecting larger is " Dictionary of Chinese Pharmacy " that nineteen thirty-five Chen Cunren writes.Pandect 2,700,000 word, receive 4300, medicine order, every medicine is introduced name, ancient books another name, basic, the place of production, form, character, composition, usefulness respectively, cured mainly, successive dynasties description textual criticism, discrimination, person of modern times's theory, fit applications, consumption, use compatibility and incompatibility of drugs, reference material etc. 21.Abundant information, comprehensively, summarize relevant discussion at all times, and drawings attached.It is first large-scale dictionary on Traditional Chinese Medicine Phylogeny.Maybe about 7,000 hundred million will be reached to Chinese herbal medicine industry total industrial output value in 2015.

Through general retrieval, do not find the scheme identical with present patent application.

Summary of the invention

The object of the invention is to: propose one and treat raynaud disease medicine.

Treatment raynaud disease medicine of the present invention, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition.

Treatment raynaud disease medicine of the present invention, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition, pulverize, packaging, obtains product.

Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.

Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.

Treatment raynaud disease medicine of the present invention, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient, make powdered granule product.

Treatment raynaud disease medicine of the present invention, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.

The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.

Detailed description of the invention

Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.

Chinese medicinal formulae of the present invention is proved recipe handed down from one's ancestors, in the past few decades, has treated many patients, has now enumerated model case as follows:

Model case clinical effectiveness:

Insult certain, man, 33 years old.Suffer from raynaud disease 1 year, disease feelings aggravation bimester of near.Card is shown in that ten fingers are pale, and band purple, have numb sensation of pricking, extremity are not warm, thin white fur of tongue, deep-thready pulse.Take treatment raynaud disease medicine of the present invention after 2 days, sensation of pricking alleviates, spiritual amelioration.Take treatment raynaud disease medicine of the present invention 25 days, the disease such as dizzy, indigestion and loss of appetite is all improved, and resumes work.Follow up a case by regular visits to 1 year, have no recurrence.

Liu, female, 43 years old.Suffer from raynaud disease 9 years, interval outbreak.This outbreak card is shown in: both hands interval is livid purple, refers to attach most importance to ten, and except hand thumb, remaining finger finger tip all has ulcer altogether.Body of the tongue is dim, and tongue is white, deep-thready pulse.With Western medicine anti-inflammatory treatment 9 days, and through debridement treatment, ulcer surface was slightly healed, and sclerderm appears in affected part.Take treatment raynaud disease medicine of the present invention again 45 days, clinical symptom remission, ulcer surface heals, and sclerderm comes off.Microcirculation tester shows: both hands blood circulation recovers normal.Follow up a case by regular visits to and do not recur for 1 year.

Claims

1. a treatment raynaud disease medicine, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition.

2. a treatment raynaud disease medicine, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition, pulverize, packaging, obtains product.

3. a treatment raynaud disease medicine, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient, make powdered granule product.

4. a treatment raynaud disease medicine, it is characterized in that: by weight, by the Radix Astragali 10-12 parts, Herba Asari 10-12 parts, Rhizoma Sparganii 10-12 parts, Radix Pseudostellariae 10-12 parts, Caulis Spatholobi 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Rhizoma Curculiginis 10-12 parts, Herba Epimedii 10-12 parts, Radix Angelicae Sinensis 10-12 parts, Fructus Lycii 10-12 parts, Fructus Liquidambaris 10-12 parts, Squama Manis 10-12 parts, Radix Clematidis 10-12 parts, Radix Saposhnikoviae 10-12 parts, 10-12 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 10-12 parts, the Radix Aucklandiae 10-12 parts, Fructus Aurantii 10-12 parts, Ramulus Cinnamomi 10-12 parts, Herba Ephedrae (processed) 10-12 parts, Rhizoma Zingiberis 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition, adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.